Anavex board change triggers full vesting of unvested equity awards after contested annual meeting

ANAVEX LIFE SCIENCES CORP.

Anavex stockholders elected six Company nominees at the Sept. 24, 2026 annual meeting; no PVG nominees were elected. Jiong Ma received 37,010,531 for and 14,315,617 against.
The contested election meant only Jiong Ma, Peter Donhauser and Claus van der Velden qualified as Incumbent Directors, less than a majority of the board.
The Board Change CIC immediately fully vested all outstanding unvested awards under Anavex's 2015, 2019 and 2022 Incentive Plans and Sandra Boenisch's PFO employment agreement.
Stockholders present or represented 54,239,204 shares, about 58.51% of outstanding common stock as of the July 31, 2026 record date; Grant Thornton was ratified as auditor.

This headline and bullets were generated automatically by deepseek-v4.1-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.